Complement Factor B (Factor B / Bb)
Zymogen of the alternative complement pathway that binds spontaneous fluid-phase C3(H2O) or target-bound C3b.
Standard vs. Optimal Reference Rangesug/mL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
150 - 350 ug/mL (15 - 35 mg/dL)
General reference distribution across unselected commercial populations.
180 - 300 ug/mL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Cleaved by Factor D into Ba and the active serine protease Bb; Bb forms the alternative C3 convertase (C3bBb) on pathogen surfaces.
Differential Diagnosis
Elevated Levels (Factor B / Bb High)
- •Acute phase reactant elevation
Low Levels (Factor B / Bb Low)
- •Alternative pathway complement consumption (C3 Glomerulopathy, Dense Deposit Disease, active aHUS)
- •Genetic Factor B mutations
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for Factor B / Bb
- Targeted organ system imaging or functional dynamic testing related to alternative pathway convertase
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Complement Factor B - The New England Journal of Medicine (2021). PMID: 34190124
- [2]Factor B / Bb Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35422901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Complement Factor B (Factor B / Bb) into overall healthspan optimization.